Modafinil and Alzheimer’s Disease: Current Evidence and Future Directions
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and behavioral symptoms. Despite numerous therapeutic efforts, effective treatments for the cognitive symptoms of AD remain limited. Modafinil, a wakefulness-promoting agent approved for sleep disorders such as narcolepsy, has gained attention for its off-label use as a cognitive enhancer. Key Takeaways…